Résultats de recherche
6 sept. 2024 · PHAXIAM Therapeutics S.A.: Analyse technique avec graphique dynamique et Temps réel Action PHAXIAM Therapeutics S.A. | PHXM | FR0011471135 | Euronext Paris
4 sept. 2024 · ERYTECH PHARMA FR0011471135 - ERYP Cotation du 16:04 04/09/24. 1,65€ -2,82%; Publicité ...
23 août 2024 · ERYTECH PHARMA FR0011471135 - ERYP Cotation du 17:55 23/08/24. 1,75€ -1,69%; Publicité ...
20 août 2024 · PHAXIAM Therapeutics SA, formerly known as ERYTECH PHARMA SA, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields...
Il y a 2 jours · L'approche de TME Pharma N.V. fonctionne en combinaison avec d'autres formes de traitement pour affaiblir les défenses de la tumeur et permettre un plus grand impact thérapeutique. Ses ...
- TME PHARMA N.V.
5 sept. 2024 · A biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. About the company. Rewards. Risk Analysis. Shareholders have been substantially diluted in the past year. Volatile share price over the past 3 months. Does not have a meaningful market cap (€17M)
Il y a 2 jours · Should You Buy or Sell ERYTECH Pharma Stock? Get The Latest ERYP Stock Analysis, Price Target, Headlines, and Short Interest at MarketBeat.
